Women of all ages needs to be apprised that the impact of intrauterine exposure to methadone, buprenorphine, or buprenorphine-naloxone on ongoing toddler enhancement continues to be uncertain. Clinicians need to additionally convey to their people that some great benefits of pharmacotherapy for OUD outweigh the pitfalls.Buprenorphine exhibits promi